{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:32:34Z","timestamp":1763141554374,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["17ZR1421300"],"award-info":[{"award-number":["17ZR1421300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00592-021-01717-7","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:02:59Z","timestamp":1618815779000},"page":"1217-1224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum metabolic signatures of subclinical atherosclerosis in patients with type 2 diabetes mellitus: a preliminary study"],"prefix":"10.1007","volume":"58","author":[{"given":"Jiaorong","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-161X","authenticated-orcid":false,"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"24","key":"1717_CR1","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL,\u00a0Beam C, Birtcher KK, Blumenthal RS et al (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 73(24):e285\u2013e350. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.003","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"1717_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CCL Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB (2016) Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus-mechanisms, management, and clinical considerations. Circulation 133(24):2459\u20132502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022194","journal-title":"Circulation"},{"issue":"5","key":"1717_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4093\/dmj.2018.0041","volume":"42","author":"CH Lee","year":"2018","unstructured":"Lee CH, Lee SW, Park SW (2018) Diabetes and subclinical coronary atherosclerosis. Diabetes Metab J 42(5):355\u2013363. https:\/\/doi.org\/10.4093\/dmj.2018.0041","journal-title":"Diabetes Metab J"},{"issue":"4","key":"1717_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000081812","volume":"18","author":"PJ Touboul","year":"2004","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M et al (2004) Mannheim intima-media thickness consensus. Cerebrovasc Dis 18(4):346\u2013349. https:\/\/doi.org\/10.1159\/000081812","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"1717_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.gheart.2016.08.006","volume":"11","author":"JF Polak","year":"2016","unstructured":"Polak JF, O\u2019Leary DH (2016) Carotid intima-media thickness as surrogate for and predictor of CVD. Glob Heart 11(3):295-312.e3. https:\/\/doi.org\/10.1016\/j.gheart.2016.08.006","journal-title":"Glob Heart"},{"issue":"5","key":"1717_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/oxfordjournals.aje.a010233","volume":"151","author":"LE Chambless","year":"2000","unstructured":"Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ et al (2000) Carotid wall thickness is predictive of incident clinical stroke: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 151(5):478\u2013487. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a010233","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1717_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/oxfordjournals.aje.a009302","volume":"146","author":"LE Chambless","year":"1997","unstructured":"Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987\u20131993. Am J Epidemiol 146(6):483\u2013494. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009302","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1717_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17(7):451\u2013459. https:\/\/doi.org\/10.1038\/nrm.2016.25","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1717_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/jdi.12723","volume":"9","author":"T Wu","year":"2018","unstructured":"Wu T, Qiao S, Shi C, Wang S, Ji G (2018) Metabolomics window into diabetic complications. J Diabetes Investig 9(2):244\u2013255. https:\/\/doi.org\/10.1111\/jdi.12723","journal-title":"J Diabetes Investig"},{"issue":"10","key":"1717_CR10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.5551\/jat.52506","volume":"27","author":"K Omori","year":"2020","unstructured":"Omori K, Katakami N, Arakawa S, Yamamoto Y, Ninomiya H, Takahara M et al (2020) Identification of plasma inositol and indoxyl sulfate as novel biomarker candidates for atherosclerosis in patients with type 2 diabetes.-Findings from metabolome analysis using GC\/MS. J Atheroscler Thromb 27(10):1053\u20131067. https:\/\/doi.org\/10.5551\/jat.52506","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"1717_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-020-01057-w","volume":"19","author":"N Katakami","year":"2020","unstructured":"Katakami N, Omori K, Taya N, Arakawa S, Takahara M, Matsuoka TA et al (2020) Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes. Cardiovasc Diabetol 19(1):75. https:\/\/doi.org\/10.1186\/s12933-020-01057-w","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 1","key":"1717_CR12","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association (2010) Standards of medical care in diabetes\u20142010. Diabetes Care 33(Suppl 1):S11\u2013S61. https:\/\/doi.org\/10.2337\/dc10-S011","journal-title":"Diabetes Care"},{"issue":"13","key":"1717_CR13","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.282.13.1247","volume":"282","author":"G Yang","year":"1999","unstructured":"Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM et al (1999) Smoking in China: findings of the 1996 national prevalence survey. JAMA 282(13):1247\u20131253. https:\/\/doi.org\/10.1001\/jama.282.13.1247","journal-title":"JAMA"},{"issue":"1","key":"1717_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-020-01020-9","volume":"19","author":"X He","year":"2020","unstructured":"He X, Su J, Ma X, Lu W, Zhu W, Wang Y et al (2020) The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes. Cardiovasc Diabetol 19(1):40. https:\/\/doi.org\/10.1186\/s12933-020-01020-9","journal-title":"Cardiovasc Diabetol"},{"key":"1717_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.aca.2014.11.015","volume":"854","author":"J Han","year":"2015","unstructured":"Han J, Lin K, Sequeira C, Borchers CH (2015) An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal Chim Acta 854:86\u201394. https:\/\/doi.org\/10.1016\/j.aca.2014.11.015","journal-title":"Anal Chim Acta"},{"issue":"1","key":"1717_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12859-020-03786-x","volume":"21","author":"D Liang","year":"2020","unstructured":"Liang D, Liu Q, Zhou K, Jia W, Xie G, Chen T (2020) IP4M: an integrated platform for mass spectrometry-based metabolomics data mining. BMC Bioinform 21(1):444. https:\/\/doi.org\/10.1186\/s12859-020-03786-x","journal-title":"BMC Bioinform"},{"issue":"12","key":"1717_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","volume":"15","author":"TR Ahmad","year":"2019","unstructured":"Ahmad TR, Haeusler RA (2019) Bile acids in glucose metabolism and insulin signalling-mechanisms and research needs. Nat Rev Endocrinol 15(12):701\u2013712. https:\/\/doi.org\/10.1038\/s41574-019-0266-7","journal-title":"Nat Rev Endocrinol"},{"key":"1717_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00804-9","author":"W Jia","year":"2020","unstructured":"Jia W, Wei M, Rajani C, Zheng X (2020) Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. https:\/\/doi.org\/10.1007\/s13238-020-00804-9","journal-title":"Protein Cell"},{"issue":"20","key":"1717_CR19","doi-asserted-by":"publisher","first-page":"30652","DOI":"10.1016\/j.cmet.2020.11.017","volume":"S1550\u20134131","author":"X Zheng","year":"2020","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J et al (2021) Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab 33(4):791\u2013803.e7. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.017","journal-title":"Cell Metab"},{"issue":"7","key":"1717_CR20","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B (2017) Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152(7):1679-1694.e3. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.055","journal-title":"Gastroenterology"},{"key":"1717_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","volume":"9","author":"K Jadhav","year":"2018","unstructured":"Jadhav K, Xu Y, Xu Y, Li Y, Xu J, Zhu Y et al (2018) Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. Mol Metab 9:131\u2013140. https:\/\/doi.org\/10.1016\/j.molmet.2018.01.005","journal-title":"Mol Metab"},{"issue":"4","key":"1717_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/cvr\/cvs368","volume":"97","author":"M Jov\u00e9","year":"2013","unstructured":"Jov\u00e9 M, Ayala V, Ram\u00edrez-N\u00fa\u00f1ez O, Serrano JC, Cassany\u00e9 A, Arola L et al (2013) Lipidomic and metabolomic analysis reveal potential plasma biomarkers of early atheromatous plaque formation in hamsters. Cardiovasc Res 97(4):642\u2013652. https:\/\/doi.org\/10.1093\/cvr\/cvs368","journal-title":"Cardiovasc Res"},{"issue":"11","key":"1717_CR23","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.phymed.2014.05.009","volume":"21","author":"YT Liu","year":"2014","unstructured":"Liu YT, Peng JB, Jia HM, Cai DY, Zhang HW, Yu CY et al (2014) UPLC-Q\/TOF MS standardized Chinese formula Xin-Ke-Shu for the treatment of atherosclerosis in a rabbit model. Phytomedicine 21(11):1364\u20131372. https:\/\/doi.org\/10.1016\/j.phymed.2014.05.009","journal-title":"Phytomedicine"},{"issue":"3","key":"1717_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1039\/c5an01970b","volume":"141","author":"P Jia","year":"2016","unstructured":"Jia P, Wang S, Xiao C, Yang L, Chen Y, Jiang W et al (2016) The anti-atherosclerotic effect of tanshinol borneol ester using fecal metabolomics based on liquid chromatography-mass spectrometry. Analyst 141(3):1112\u20131120. https:\/\/doi.org\/10.1039\/c5an01970b","journal-title":"Analyst"},{"issue":"9","key":"1717_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP et al (2017) Increased secondary\/primary bile acid ratio in chronic heart failure. J Card Fail 23(9):666\u2013671. https:\/\/doi.org\/10.1016\/j.cardfail.2017.06.007","journal-title":"J Card Fail"},{"issue":"12","key":"1717_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jacc.2016.06.044","volume":"68","author":"Y Fan","year":"2016","unstructured":"Fan Y, Li Y, Chen Y, Zhao YJ, Liu LW, Li J et al (2016) Comprehensive metabolomic characterization of coronary artery diseases. J Am Coll Cardiol 68(12):1281\u20131293. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.044","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1717_CR27","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.amjcard.2019.03.017","volume":"123","author":"A Alonso","year":"2019","unstructured":"Alonso A, Yu B, Sun YV, Chen LY, Loehr LR, O\u2019Neal WT et al (2019) Serum metabolomics and incidence of atrial fibrillation (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 123(12):1955\u20131961. https:\/\/doi.org\/10.1016\/j.amjcard.2019.03.017","journal-title":"Am J Cardiol"},{"issue":"5","key":"1717_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA (2013) Pleiotropic roles of bile acids in metabolism. Cell Metab 17(5):657\u2013669. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.013","journal-title":"Cell Metab"},{"issue":"4","key":"1717_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.28712","volume":"64","author":"Y Xu","year":"2016","unstructured":"Xu Y, Li F, Zalzala M, Xu J, Gonzalez FJ, Adorini L et al (2016) Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology 64(4):1072\u20131085. https:\/\/doi.org\/10.1002\/hep.28712","journal-title":"Hepatology"},{"issue":"2","key":"1717_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2013.08.006","volume":"230","author":"MH Davidson","year":"2013","unstructured":"Davidson MH, Voogt J, Luchoomun J, Decaris J, Killion S, Boban D et al (2013) Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans. Atherosclerosis 230(2):322\u2013329. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.08.006","journal-title":"Atherosclerosis"},{"issue":"2","key":"1717_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","volume":"14","author":"AL Jonsson","year":"2017","unstructured":"Jonsson AL, B\u00e4ckhed F (2017) Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 14(2):79\u201387. https:\/\/doi.org\/10.1038\/nrcardio.2016.183","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1717_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S et al (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8(1):845. https:\/\/doi.org\/10.1038\/s41467-017-00900-1","journal-title":"Nat Commun"},{"issue":"5","key":"1717_CR33","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jvs.2017.09.029","volume":"68","author":"CA Cason","year":"2018","unstructured":"Cason CA, Dolan KT, Sharma G, Tao M, Kulkarni R, Helenowski IB et al (2018) Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes. J Vasc Surg 68(5):1552-1562.e7. https:\/\/doi.org\/10.1016\/j.jvs.2017.09.029","journal-title":"J Vasc Surg"},{"key":"1717_CR34","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.molmet.2020.100976","volume":"36","author":"BA Kappel","year":"2020","unstructured":"Kappel BA, De Angelis L, Heiser M, Ballanti M, Stoehr R, Goettsch C et al (2020) Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment. Mol Metab 36:100976. https:\/\/doi.org\/10.1016\/j.molmet.2020.100976","journal-title":"Mol Metab"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01717-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01717-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T17:10:06Z","timestamp":1627405806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01717-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01717-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"1 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital and was in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent prior to their inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}